(Hypertension. 1999;33:482-486.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From the Department of Pharmacology and Toxicology (M.M.), Wright State University School of Medicine, Dayton, OH; the Hypertension Center and Department of Physiology and Pharmacology (M.F.C., S.M.B., D.I.D.), Wake Forest University Medical Center, Winston-Salem, NC; and the Department of Medicine (M.I.O., T.M.C.), Duke University and VA Medical Center, Durham, NC.
Correspondence to Mariana Morris, PhD, Department of Pharmacology and Toxicology, Box 927, Wright State University School of Medicine, Dayton, OH 45401. E-mail mmorris{at}wright.edu
| Abstract |
|---|
|
|
|---|
Key Words: central nervous system hypothalamus vasopressin water balance blood pressure
| Introduction |
|---|
|
|
|---|
The question that has arisen is the role of the specific AT1 subtypes in the responses. Autoradiographic techniques used to measure receptor density do not distinguish between AT1a and AT1b subtypes because of the structural similarity of the receptors.15 16 17 18 Likewise, specific pharmacological antagonists are not available. Gene deletion or knockout (KO) methods provide a new way of separating the receptor subtypes in an in vivo model. A comparison of the AT1a and AT1b receptor KO strains supports the idea that AT1a receptors are critical in blood pressure and fluid balance regulation. AT1aKO mice show a reduced blood pressure and a lack of responsiveness to Ang II.19 20 In contrast, deletion of AT1b receptors results in few phenotypic changes.21 AT1aKO mice also show deficits in renal concentrating ability, increases in water intake, and a reduction in stimulus-induced vasopressin secretion.22 23
We proposed to examine osmotic/Ang interactions in the AT1aKO mouse strain to study the mechanisms regulating the AT1 receptor subtypes and their role in the control of vasopressin secretion. With the use of water deprivation as the stimulus, we determined whether osmotic stimulation alters the Ang receptor subtypes (AT1a and AT1b and AT2) and whether the AT1a receptors are involved in dehydration-induced vasopressin secretion.
| Methods |
|---|
|
|
|---|
Receptor Autoradiography
The autoradiographic technique has been described in
detail previously.10 24 25 26 Tissues were removed from the
animal and frozen on dry ice. For storage, tissues were coated in
cryoprotectant to protect from desiccation, allowing for optimal
cryostat sectioning. Series of adjacent sections (14 µm) were
placed on different slides so that adjacent sections could be incubated
in each of the conditions described below. To identify the receptor
subtypes, 0.4 nmol/L of
125I-[Sar1-Thr8]Ang
II (2200 Ci/mmol) was incubated both with and without 3 µmol/L
unlabeled Ang II, the AT1 antagonist
losartan, or the AT2 antagonist PD 123319. To
obtain an index of the apparent maximal binding density, total specific
binding at this near-saturating concentration of
125I-[Sar1-Thr8]Ang
II was used for comparisons of density among groups.
Precise quantification of film autoradiograms for bound peptide was carried out with the use of computerized densitometry (Micro Computer Imaging Device; Imaging Research Inc) after exposing 14C standards with the tissue sections. A conversion factor relates 14C to 125IAng II in fmol/mg protein.26 Different exposure times were used to obtain accurate readings for high, moderate, and low densities of binding according to the linear range of the film. Measurements were taken from at least 3 different areas in 2 different tissue sections for each condition (ie, in the absence or presence of each competitor). Slides were counter-stained with hematoxylin and eosin or cresyl violet to verify anatomic localization of the binding.
Radioimmunoassay
Plasma was separated and stored frozen (70°C) until
radioimmunoassay measurement. The plasma samples (200 µL) were
extracted with acetone and petroleum ether. The lyophilized extract was
resuspended in assay buffer, and vasopressin concentrations were
measured with the use of a specific and sensitive
assay.27
Statistical Analysis
The data are presented as the mean±SEM. ANOVA for
multiple groups was used to determine significance (P<0.05)
followed by a Newman-Keuls post hoc comparison.
| Results |
|---|
|
|
|---|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
The relationship between brain Ang systems in the control of water balance, blood pressure, and vasopressin secretion has been documented using a variety of approaches. Central injection of Ang II or hypertonic saline produces drinking, antidiuresis, an increase in blood pressure, and vasopressin secretion. These effects can be almost completely blocked by AT1 antagonists and AT1 receptor antisense and brain lesions.2 13 28 29 30 Likewise, the responses to dehydration are thought to involve the RAS because Ang antagonists attenuate drinking.12 31 AT2 antagonists have been reported to block at least a part of the drinking responses,13 14 which would be consistent with our observation of a small population of AT2 receptors in the PVN. Ang is present in the magnocellular neurosecretory nuclei and in pathways connecting the rostral forebrain with the hypothalamus.16 32 Thus, it would be predicted that removal of this important system would affect blood pressure, fluid balance, and vasopressin secretion.
Characterization studies of the AT1aKO mouse strains reported lower blood pressures and a lack of pressor responsiveness to Ang II.19 20 Oliverio and colleagues reported alterations in fluid balance in this model, an increase in water intake, a decrease in urine osmolality, and a deficit in the ability to concentrate in response to dehydration.22 The focus of our studies was on the central neuroendocrine changes with the idea that these may also be important in the physiological alterations. In the absence of AT1a receptors, 48 hours of water deprivation produced no change in plasma vasopressin in the face of increased plasma osmolality. The data support the idea that central AT1 receptors in mice are critically involved in osmosis-induced peptide secretion. Furthermore, they show that results obtained with a genetic approach are comparable to those obtained with pharmacological antagonists. For example, the vasopressin response to increased osmolality in isolated hypothalami was blocked by an Ang antagonist33 as was dehydration-induced secretion in the whole animal.34 In this study, plasma vasopressin was used as the end point to evaluate osmotic responsiveness. However, when other indices of the vasopressin axis were measured, there was evidence that osmosensitivity is not lost in AT1aKO mice. Posterior pituitary vasopressin content was reduced after dehydration in AT1aKO animals, and c-Fos expression, an index of neural activation, was observed in neurons in the rostral forebrain and PVN of dehydrated AT1aKO mice.23 35 Further studies are required to determine the nature of the alterations in the hypothalamic vasopressin system in mice lacking the AT1a receptors, particularly the time course of the changes.
Previous studies have shown that dehydration or changes in salt intake in rats alter brain Ang-receptor density in SFO and AP but not PVN.4 5 6 8 9 The results in mice show that dehydration increased AT1 receptors in the PVN and the AP, with insufficient brain sections in the SFO region to permit analysis. Differences were also noted in the time courses of the receptor changes in mice and rats. In mice, receptor changes were seen after 2 days of dehydration, whereas in rats the earliest time to see changes was after 5 days of dehydration.4 Given the metabolic rate and water turnover in mice (daily intake of 4 to 6 mL per 30 g animal), water deprivation for 48 hours is a severe challenge, probably a greater stimulus than in rats. The reason for the species differences in the localization of the response, PVN and AP, is not known. It may be related to the magnitude of the stimulus, the time course, or a difference in central nervous system organization. Certainly the data support the common theme of interactions between volume status and brain Ang systems, with activation occurring in regions important in blood pressure and volume control.
One of the purposes of the present investigation of the AT1aKO model was to examine the interaction between the Ang-receptor subtypes under control and stimulated conditions. We speculated that in the absence of the AT1a receptor there would be an upregulation of the AT1b receptor or perhaps changes in AT2 receptors. The results provided no direct evidence of such an interaction. There was almost no specific binding in the AT1aKO mice in the brain regions studied, and no change was noted with dehydration. Studies in which in situ hybridization and polymerase chain reaction methods were used for the localization and quantification of the mRNA for the AT1-receptor subtypes showed that AT1b receptors were of a lower density and were expressed in brain, testes, adrenal, kidney, and pituitary.4 7 8 15 18 36 In the rat brain, there is strong evidence for the presence of AT1b mRNA in AP and more controversy regarding its localization in SFO.4 15 18 The question is whether the mRNA is directly translatable into receptor protein. As mentioned previously, in normal animals receptor-binding techniques cannot be used to differentiate the receptor subtypes. However, the AT1aKO animal, which lacks the homologous receptor, should provide a model to study expression of the AT1b receptor. However, there was little evidence for the receptor except in the AP, which showed low levels of binding (10 versus 40 fmol/mg protein, AT1aKO versus control mice). There are physiological studies that indicate that the AT1b receptor is functionally active, as demonstrated by pressor and drinking responses to Ang II after treatment with RAS antagonists in AT1aKO mice.37 38
These results emphasize the usefulness of gene deletion models for the study of physiological function. The present data in the AT1aKO mouse document the complexities that result from the removal of a receptor that is critical in the regulation of cardiovascular and endocrine function. Changes are observed in the response to water deprivation that suggest that the AT1a receptor is important in the osmotic control of vasopressin release. The results further emphasize the interactions between volume status and the central Ang II receptors, with data supporting a role for AT1a rather than AT1b subtypes in mouse brain and pituitary.
| Acknowledgments |
|---|
Received September 17, 1998; first decision October 12, 1998; accepted October 26, 1998.
| References |
|---|
|
|
|---|
2. Buggy J, Hoffman WE, Phillips MI, Fisher AE, Johnson AK. Osmosensitivity of rat third ventricle and interactions with angiotensin. Am J Physiol.. 1979;236:R75R82.
3. Reid IA, Schwartz J, Ben L, Maselli J, Keil LC. Interactions between vasopressin and the renin-angiotensin system. Prog Brain Res.. 1983;60:475491.[Medline] [Order article via Infotrieve]
4.
Sanvitto GL, Johren O, Hauser W, Saavedra JM. Water
deprivation upregulates ANG II AT1 binding and mRNA in rat
subfornical organ and anterior pituitary. Am J Physiol.. 1997;273:E156E163.
5. Hwang BH, Wu JY, Severs WB. Effects of chronic dehydration on angiotensin II receptor binding in subfornical organ, paraventricular hypothalamic nucleus and adrenal medulla of Long-Evans rats. Neurosc Lett.. 1986;65:3540.[Medline] [Order article via Infotrieve]
6.
Ray PE, Castren E, Ruley EJ, Saavedra JM. Different
effects of sodium or chloride depletion on angiotensin II
receptors in rats. Am J Physiol.. 1990;258:R1008R1015.
7. Wang DH, Du Y, Yao A, Hu Z. Regulation of type 1 angiotensin II receptor and its subtype gene expression in kidney by sodium loading and angiotensin infusion. J Hypertens.. 1996;14:14091415.[Medline] [Order article via Infotrieve]
8. Sandberg K, Ji H, Catt KJ. Regulation of angiotensin II receptors in rat brain during dietary sodium changes. Hypertension. 1994;23(suppl I):I-137I-141.
9.
Israel A, Saavedra JM, Plunkett LM. Water
deprivation upregulates angiotensin receptors
in rat anterior pituitary. Am J Physiol.. 1985;248:E264E267.
10.
Li P, Morris M, Diz DI, Ferrario CM, Ganten D, Callahan
MF. Role of paraventricular angiotensin AT1
receptors in salt-sensitive hypertension in mRen-2 transgenic rats.
Am J Physiol.. 1996;270:R1178R1181.
11. Bruner CA, Weaver JM, Fink GD. Sodium-dependent hypertension produced by chronic central angiotensin II infusion. Am J Physiol.. 1985;249:H321H327.
12. Reis LC, Saad WA, Camargo LA, Renzi A, Menani V, Silveira JE. Inhibitory effect of DUP-753 on the drinking responses of rats to central administration of noradrenaline and angiotensin II and to dehydration. Braz J Med Biol Res.. 1996;29:507510.[Medline] [Order article via Infotrieve]
13. Hogarty DC, Speakman EA, Puig V, Phillips MI. The role of angiotensin AT1 and A2 receptors in the pressor, drinking and vasopressin responses to central angiotensin. Brain Res.. 1992;586:289294.[Medline] [Order article via Infotrieve]
14. Culman J, Hohle S, Qadri F, Edling O, Blume A, Lebrun C, Unger T. Angiotensin as neuromodulator/neurotransmitter in control of body fluid and electrolyte homeostasis. Clin Exp Hypertens.. 1995;17:281293.
15. Kakar SS, Sellers JC, Devor DC, Musgrove LC, Neill JD. Differential expression of angiotensin II receptor subtype mRNAs (AT-1A and AT-1B) in the brain. Biochem Biophys Res Commun.. 1992;183:10901096.[Medline] [Order article via Infotrieve]
16. Johren O, Imboden H, Hauser W, Maye I, Sanvitto GL, Saavedra JM. Localization of angiotensin-converting enzyme, angiotensin II, angiotensin subtypes, and vasopressin in the mouse hypothalamus. Brain Res. 199;757:218227.
17. Lenkei Z, Corvol P, Llorens-Cortes C. The angiotensin receptor subtype AT1a predominates in rat forebrain areas involved in blood pressure, body fluid homeostasis and neuroendocrine control. Mol Brain Res.. 1995;30:5360.[Medline] [Order article via Infotrieve]
18.
Johren O, Saavedra JM. Expression of AT1a and AT1b
angiotensin II receptor messenger RNA in forebrain of
2-wk-old rats. Am J Physiol.. 1996;271:E104E112.
19.
Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N,
Smithies O, Coffman TM. Regulation of blood pressure by the type 1A
angiotensin II receptor gene. Proc Natl Acad Sci
U S A.. 1995;92:35213525.
20.
Sugaya T, Nishimatsu S, Tanimoto K, Takimoto E,
Yamagishi T, Imamura K, Goto S, Imaizumi K, Hisada Y, Otsuka A, Uchida
H, Sugiura M, Fukuta K, Fukamizu A, Murakami K. Angiotensin
II type 1a receptor-deficient mice with hypotension and hyperreninemia.
J Biol Chem.. 1995;270:1871918722.
21.
Chen X, Li W, Yoshida H, Tsuchida S, Nishimura H,
Takemoto F, Okubo S, Fogo A, Matsusaka T, Ichikawa I. Targeting
deletion of angiotensin type 1B receptor gene in the mouse.
Am J Physiol.. 1997;272:F299F304.
22. Oliverio MI, Best CF, Li P, Callahan MF, Morris M, Coffman TM. The absence of AT1A receptors causes abnormal water metabolism. Hypertension.. 1997;30:496. Abstract.
23. Li P, Callahan MF, Coffman TM, Oliverio MI, Morris M. Altered vasopressin axis in the AT-1a knockout mouse. FASEB J.. 1997;11:A462. Abstract.
24. Chappell MC, Diz DI, Jacobsen DW. Pharmacological characterization of angiotensin II binding sites in the canine pancreas. Peptides.. 1992;13:313318.[Medline] [Order article via Infotrieve]
25. Diz DI, Ferrario CM. Bidirectional transport of angiotensin II binding sites in the vagus nerve. Hypertension. 1988;11(suppl I):I-139I-143.
26. Goldfarb DA, Diz DI, Tubbs RR, Ferrario CM, Novick AC. Angiotensin II receptor subtypes in human renal cortex and carcinoma. J Urol.. 1994;151:208213.[Medline] [Order article via Infotrieve]
27. Rocha MJA, Callahan MF, Sundberg DK, Morris M. Sinoaortic denervation alters the molecular and endocrine responses to salt loading. Neuroendocrinology.. 1993;57:729739.[Medline] [Order article via Infotrieve]
28. Hohle S, Spitznagel H, Rascher W, Culman J, Unger T. Angiotensin AT1 receptor-mediated vasopressin release and drinking are potentiated by an AT2 receptor antagonist. Eur J Pharmacol.. 1995;275:277282.[Medline] [Order article via Infotrieve]
29.
Qadri F, Culman J, Veltmar A, Maas K, Rascher W, Unger
T. Angiotensin II-induced vasopressin release is mediated
through alpha-1 adrenoceptors and angiotensin II AT1
receptors in the supraoptic nucleus. J Pharmacol Exp
Ther.. 1993;267:567574.
30. Meng H, Wielbo D, Gyurko R, Phillips MI. Antisense oligonucleotide to AT1 receptor mRNA inhibits central angiotensin induced thirst and vasopressin. Regul Pept.. 1994;54:543551.[Medline] [Order article via Infotrieve]
31. Widdop RE, Gardiner SM, Bennett T. Effects of angiotensin II AT1- or AT2-receptor antagonists on drinking evoked by angiotensin II or water deprivation in rats. Brain Res.. 1994;648:4652.[Medline] [Order article via Infotrieve]
32. Lind RW, Swanson LW, Ganten D. Angiotensin II immunoreactive pathways in the central nervous system of the rat: evidence for a projection from the subfornical organ to the paraventricular nucleus of the hypothalamus. Clin Exp Hypertens [A].. 1984;6:19151920.[Medline] [Order article via Infotrieve]
33.
Sladek CD, Blair ML, Ramsay DJ. Further studies on the
role of angiotensin in the osmotic control of vasopressin
release by the organ-cultured rat hypothalamo-neurohypophyseal system.
Endocrinology.. 1982;111:599607.
34.
Yamaguchi K, Hama H, Sakaguchi T, Negoro H, Kamoi K.
Effects of intraventricular injection of
Sar1-Ala8-angiotensin II on plasma vasopressin level
increased by angiotensin II and by water
deprivation in conscious rats. Acta
Endocrinologica.. 1980;93:407412.
35. Means S, Oliverio MI, Coffman TM, Morris M. Increased hypothalamic vasopressin and c-Fos responses in mice lacking the Angiotensin AT1a receptor. Society for Neuroscience.. 1998;24:54.13. Abstract.
36.
Burson JM, Aguilera G, Gross KW, Sigmund CD.
Differential expression of angiotensin receptor 1A and 1B
in mouse. Am J Physiol.. 1994;267:E260E267.
37.
Oliverio MI, Best CF, Kim HS, Arendshorst WJ, Smithies
O, Coffman TM. Angiotensin II responses in AT1A
receptor-deficient mice: a role for AT1B receptors in blood pressure
regulation. Am J Physiol.. 1997;272:F515F520.
38. Davisson RL, Beltz TG, Oliverio MI, Johnson AK, Smithies O, Coffman TM, Sigmund CD. Function of central AT1A and AT1B receptors revealed by gene targeting. Hypertension.. 1998;32:595. Abstract.
This article has been cited by other articles:
![]() |
E. Lazartigues, P. Sinnayah, G. Augoyard, C. Gharib, A. K. Johnson, and R. L. Davisson Enhanced water and salt intake in transgenic mice with brain-restricted overexpression of angiotensin (AT1) receptors Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2008; 295(5): R1539 - R1545. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang and C. W. Bourque Amplification of Transducer Gain by Angiotensin II-Mediated Enhancement of Cortical Actin Density in Osmosensory Neurons J. Neurosci., September 17, 2008; 28(38): 9536 - 9544. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Farah, K. M. Elased, and M. Morris Genetic and dietary interactions: role of angiotensin AT1a receptors in response to a high-fructose diet Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1083 - H1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Wichi, V. Farah, Y. Chen, M. C. Irigoyen, and M. Morris Deficiency in angiotensin AT1a receptors prevents diabetes-induced hypertension Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1184 - R1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, H. Chen, A. Hoffmann, D. R. Cool, D. I. Diz, M. C. Chappell, A. Chen, and M. Morris Adenovirus-Mediated Small-Interference RNA for In Vivo Silencing of Angiotensin AT1a Receptors in Mouse Brain Hypertension, February 1, 2006; 47(2): 230 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, H. Chen, and M. Morris Enhanced osmotic responsiveness in angiotensin AT1a receptor deficient mice: evidence for a role for AT1b receptors Exp Physiol, September 1, 2005; 90(5): 739 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, L. F. Joaquim, V. M. Farah, R. B. Wichi, R. Fazan Jr., H. C. Salgado, and M. Morris Cardiovascular autonomic control in mice lacking angiotensin AT1a receptors Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2005; 288(4): R1071 - R1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhou, Y. Chen, W. P. Dirksen, M. Morris, and M. Periasamy AT1b Receptor Predominantly Mediates Contractions in Major Mouse Blood Vessels Circ. Res., November 28, 2003; 93(11): 1089 - 1094. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Davisson Physiological genomic analysis of the brain renin-angiotensin system Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2003; 285(3): R498 - R511. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Johren, C. Golsch, A. Dendorfer, F. Qadri, W. Hauser, and P. Dominiak Differential Expression of AT1 Receptors in the Pituitary and Adrenal Gland of SHR and WKY Hypertension, April 1, 2003; 41(4): 984 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, M. Iwai, L. Wu, T. Shiuchi, T. Jinno, T.-X. Cui, and M. Horiuchi Role of AT2 receptor in the brain in regulation of blood pressure and water intake Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H116 - H121. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cervenka, V. Horacek, I. Vaneckova, J. A. Hubacek, M. I. Oliverio, T. M. Coffman, and L. G. Navar Essential Role of AT1A Receptor in the Development of 2K1C Hypertension Hypertension, November 1, 2002; 40(5): 735 - 741. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. A. Janssen and J. F. M. Smits Autonomic control of blood pressure in mice: basic physiology and effects of genetic modification Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1545 - R1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sinnayah, T. E. Lindley, P. D. Staber, M. D. Cassell, B. L. Davidson, and R. L. Davisson Selective Gene Transfer to Key Cardiovascular Regions of the Brain: Comparison of Two Viral Vector Systems Hypertension, February 1, 2002; 39(2): 603 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Morris, S. Means, M. I. Oliverio, and T. M. Coffman Enhanced central response to dehydration in mice lacking angiotensin AT1a receptors Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2001; 280(4): R1177 - R1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen and M. Morris Differentiation of Brain Angiotensin Type 1a and 1b Receptor mRNAs : A Specific Effect of Dehydration Hypertension, February 1, 2001; 37(2): 692 - 697. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger International Union of Pharmacology. XXIII. The Angiotensin II Receptors Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |